The agency is also evaluating if there's a need for further regulatory action based on reports of hematologic malignancies from clinical trials of the therapy.

NovoCure and Zai Lab report PANOVA-3 trial success with TTFields therapy, achieving significant survival benefits for ...

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics ...

Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy ...

Skull-base tumors, a subset of neoplasms, present a formidable challenge in the field of oncology due to their complex anatomical location at the interface of the brain and skull-base. These tumors ...

Men with cardiovascular disease risk factors, including obesity, may face earlier brain health decline compared to women up ...